Dec 03,2018

One Drop Raises $11.6M In Equity and Debt Financing

The document is a Form D filing submitted to the US Securities and Exchange Commission by One Drop, a diabetes management platform. The filing indicates that One Drop has raised $11,580,000 USD through the issuance of convertible promissory notes to an undisclosed group of investors. The notes are convertible into equity shares in the company at a later date. The funds will be used to support the company's growth and expansion efforts.

FUNDING DEBT FINANCE
View Analyst & Ambassador Comments
Go to original news
Jan 10,2019

Sentio Solutions Raises $4.5M and Launches Feel to Expand Access to Mental Health Care and Provide On-Time Interventions to 500 Million People Living with Mental Health Issues Around the World

Sentio, a company developing biomarkers and digital therapeutics for mental health, today announced it has raised $4.5 million in seed funding led by Felicis Ventures, with participation from Anthemis Exponential Ventures, and SOSV. The company combines its proprietary emotion sensing technology with Cognitive Behavioral Therapy (CBT) to bring a data-driven approach to the field of mental health for the very first time, while providing real-time interventions and care to those in need of emotional and mental health support. The latest investment, which brings the total raised to date to $6.3 million, will enable Sentio to expand access to its Feel program through partnerships with health plans, life insurance providers, employers, and health systems.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Jan 21,2019

Kaia Health Raises $10M in Series A Funding

Kaia Health, a Munich, Germany-based digital therapeutics company, raised $10m in Series A funding. The round was led by Balderton Capital. The company intends to use the funds to rollout the app in the USA, including a new office in New York City, and fund further clinical studies.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Feb 18,2019

Cipla To Acquire Stake In VC-Backed Digital Therapeutics Startup Wellthy

Cipla Ltd has agreed to acquire an 11.71 % stake in health-tech startup Wellthy Therapeutics Pvt. Ltd for Rs 10.5 crore ($1.5 million), India's third-largest drugmaker said on Monday. As part of the agreement, the two companies will offer a combination of pharmacotherapy and digital therapeutics for improved patient outcomes in the chronic therapies of diabetology and cardiology, Cipla said in a stock-exchange filing.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Apr 09,2019

18 Startups Selected for Batch Two of the "Insurtech Europe powered by Plug and Play" Program

Insurtech Europe, Plug and Play's Insurtech platform based in Munich, Germany, announced today the 18 startups have been selected for its second batch. The "Insurtech Europe powered by Plug and Play" program aims to facilitate pilots, POCs, and business development opportunities for the participating startups and our corporate partners Allianz, Munich Re, Versicherungskammer Bayern, Talanx, Irish Life, Willis Towers Watson, Swiss Re, and Generali Germany. One of the selected startups, Fosanis, supports cancer patients coping with their mental and medical challenges through their digital Mika App.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Apr 25,2019

Meru Health raises $4.2M in Funding and Publishes Strong Clinical Outcomes

Meru Health, a digital clinic for greater mental health, announced today that is has secured $4.2M in Series Seed financing from Freestyle Capital, Bonit Capital, Y Combinator, Lifeline Ventures and IT-Farm. Meru Health, a Y Combinator 2018 company and currently participating in the Texas Medical Center TMCx Accelerator in Houston, has developed a licensed-clinician-supported, mobile phone-based digital therapeutic program for depression and anxiety. This financing will support additional clinical validation and preparation for larger scale rollout to health systems and large employers in several states across the U.S.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Jun 21,2019

Boehringer leads investment in digital therapy for myopia

Digital startup Dopavision has raised cash in a seed funding round backed by Boehringer Ingelheim, to develop a smartphone-based digital therapy for myopia (short-sightedness). Lead investor was Boehringer Ingelheim Venture Fund, joined by business angel Ralf Meister and existing shareholder Flying Health in the financing round in May. The team will use the capital to perform pre-clinical experiments, making it one of the world’s first digital therapeutics to be validated in an animal model.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Sep 04,2019

SAP.iO Launches Enterprise Health-Focused Startup Accelerator Program in New York

The SAP.iO program is designed to accelerate startups working within healthcare: hospital system providers, employee health and wellness solutions, medical devices and health IT. SAP.iO will provide access to curated mentorship, exposure to SAP technology and application programming interfaces (APIs), and opportunities to collaborate with SAP customers to each of the seven early-stage startups chosen for the program. The SAP.iO Foundry New York cohort includes 7 startups including SilverCloud Health.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Dec 13,2019

Luminopia Raises $11.1M from Investors in Equity

Luminopia has registered a SEC form stating that the company received $11.1 million funding.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Dec 16,2019

Trainer Rx Announces $12M Funding Round and New Company Name of RecoveryOne

Trainer Rx, which since 2014 has been a leader in musculoskeletal (MSK) recovery, today announces its name change to RecoveryOne. The new name reflects the expansion of the company’s focus to align with health plans and value-based health systems that share its objective of enabling their members with the most effective, cost-efficient means of recovery. The change also coincides with a $12 million funding round led by Cigna Ventures, with significant participation from existing investor 7wire Ventures and personal participation by members of the management team. With the new name and capital, the company will strengthen its ability to reach a broader population suffering from MSK conditions.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING